168 related articles for article (PubMed ID: 37973685)
1. Optimal fracture prediction thresholds for therapy onset, established from FRAX and Garvan algorithms: a longitudinal observation of the population representative female cohort from the RAC-OST-POL Study.
Pluskiewicz W; Werner A; Bach M; Adamczyk P; Drozdzowska B
Arch Osteoporos; 2023 Nov; 18(1):136. PubMed ID: 37973685
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk prediction in postmenopausal women from GO Study: the comparison between FRAX, Garvan, and POL-RISK algorithms.
Pluskiewicz W; Werner A; Bach M; Adamczyk P; Drozdzowska B
Arch Osteoporos; 2024 May; 19(1):39. PubMed ID: 38755326
[TBL] [Abstract][Full Text] [Related]
3. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA
Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250
[TBL] [Abstract][Full Text] [Related]
4. Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women's Health Initiative Study.
Crandall CJ; Larson J; LaCroix A; Cauley JA; LeBoff MS; Li W; LeBlanc ES; Edwards BJ; Manson JE; Ensrud K
J Gen Intern Med; 2019 Feb; 34(2):235-242. PubMed ID: 30334182
[TBL] [Abstract][Full Text] [Related]
5. FRAX calculator and Garvan nomogram in male osteoporotic population.
Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Leszczynski P; Wichrowska H; Napiórkowska L; Stuss M; Ptaszek A; Kostyk T; Golba KS; Garbacz W; Drozdzowska B
Aging Male; 2014 Sep; 17(3):174-82. PubMed ID: 24456527
[TBL] [Abstract][Full Text] [Related]
6. External validation and comparison of three prediction tools for risk of osteoporotic fractures using data from population based electronic health records: retrospective cohort study.
Dagan N; Cohen-Stavi C; Leventer-Roberts M; Balicer RD
BMJ; 2017 Jan; 356():i6755. PubMed ID: 28104610
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk and fracture prevalence in women from outpatient osteoporosis clinic and subjects from population-based sample: A comparison between GO Study and RAC-OST-POL cohorts.
Pluskiewicz W; Adamczyk P; Drozdzowska B
Adv Clin Exp Med; 2023 Jan; 32(1):65-69. PubMed ID: 36135818
[TBL] [Abstract][Full Text] [Related]
8. Hip Fracture Risk Assessment Tools for Adults Aged 80 Years and Older.
Ensrud KE; Schousboe JT; Crandall CJ; Leslie WD; Fink HA; Cawthon PM; Kado DM; Lane NE; Cauley JA; Langsetmo L
JAMA Netw Open; 2024 Jun; 7(6):e2418612. PubMed ID: 38941095
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fracture risk calculators in elderly fallers: a hospital-based cross-sectional study.
Todorov G; Brook S; Quah Qin Xian N; Von Widekind S; Freudenthal B; Comninos AN
BMJ Open; 2022 Jul; 12(7):e060282. PubMed ID: 35820750
[TBL] [Abstract][Full Text] [Related]
10. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the FRAX and Garvan fracture risk calculators in older women.
Bolland MJ; Siu AT; Mason BH; Horne AM; Ames RW; Grey AB; Gamble GD; Reid IR
J Bone Miner Res; 2011 Feb; 26(2):420-7. PubMed ID: 20721930
[TBL] [Abstract][Full Text] [Related]
12. The utility of absolute risk prediction using FRAX® and Garvan Fracture Risk Calculator in daily practice.
van Geel TA; Eisman JA; Geusens PP; van den Bergh JP; Center JR; Dinant GJ
Maturitas; 2014 Feb; 77(2):174-9. PubMed ID: 24287178
[TBL] [Abstract][Full Text] [Related]
13. Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub-Study of the FRISBEE Cohort.
Baleanu F; Iconaru L; Charles A; Kinnard V; Fils JF; Moreau M; Karmali R; Surquin M; Benoit F; Mugisha A; Paesmans M; Laurent MR; Bergmann P; Body JJ
JBMR Plus; 2021 Sep; 5(9):e10532. PubMed ID: 34532617
[TBL] [Abstract][Full Text] [Related]
14. Reasons for discrepancies in hip fracture risk estimates using FRAX and Garvan calculators.
Billington EO; Gamble GD; Reid IR
Maturitas; 2016 Mar; 85():11-8. PubMed ID: 26857874
[TBL] [Abstract][Full Text] [Related]
15. Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression.
Beaudoin C; Moore L; Gagné M; Bessette L; Ste-Marie LG; Brown JP; Jean S
Osteoporos Int; 2019 Apr; 30(4):721-740. PubMed ID: 30877348
[TBL] [Abstract][Full Text] [Related]
16. High fracture probability predicts fractures in a 4-year follow-up in women from the RAC-OST-POL study.
Pluskiewicz W; Adamczyk P; Czekajło A; Grzeszczak W; Drozdzowska B
Osteoporos Int; 2015 Dec; 26(12):2811-20. PubMed ID: 26168766
[TBL] [Abstract][Full Text] [Related]
17. Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
Pluskiewicz W; Adamczyk P; Drozdzowska B
Osteoporos Int; 2021 Oct; 32(10):2043-2049. PubMed ID: 33818635
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram.
Sandhu SK; Nguyen ND; Center JR; Pocock NA; Eisman JA; Nguyen TV
Osteoporos Int; 2010 May; 21(5):863-71. PubMed ID: 19633880
[TBL] [Abstract][Full Text] [Related]
19. Increased cortical porosity and reduced cortical thickness of the proximal femur are associated with nonvertebral fracture independent of Fracture Risk Assessment Tool and Garvan estimates in postmenopausal women.
Kral R; Osima M; Borgen TT; Vestgaard R; Richardsen E; Bjørnerem Å
PLoS One; 2017; 12(9):e0185363. PubMed ID: 28945789
[TBL] [Abstract][Full Text] [Related]
20. Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.
Agarwal A; Leslie WD; Nguyen TV; Morin SN; Lix LM; Eisman JA
Osteoporos Int; 2022 Mar; 33(3):541-548. PubMed ID: 34839377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
